As your therapy operations scale from early-phase clinical trials to larger populations in late-stage trials and commercialization, your supply chain complexity—and risk—increases. Anticipating common setbacks and actively planning for their solution requires a specialized and collaborative approach with your supply chain logistics partner.
Keep these key considerations top of mind as you evaluate whether potential partners have the experience, expertise and relationships required for the successful transport and delivery of your cell and gene therapy.